Elocon

Dermatophytosis, Asthma, Itching + 14 more

Treatment

2 FDA approvals

20 Active Studies for Elocon

What is Elocon

Mometasone furoate

The Generic name of this drug

Treatment Summary

Mometasone furoate is a steroid medication that is used to treat asthma, allergies, and certain skin conditions. It is much stronger than other corticosteroid drugs and comes in the form of a dry powder inhaler, nasal spray, and ointment.

Elocon

is the brand name

image of different drug pills on a surface

Elocon Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Elocon

Mometasone furoate

1987

114

Approved as Treatment by the FDA

Mometasone furoate, also known as Elocon, is approved by the FDA for 2 uses including Asthma and Asthma .

Asthma

Helps manage Asthma

Asthma

Helps manage Asthma

Effectiveness

How Elocon Affects Patients

Mometasone is a type of synthetic steroid that attaches to glucocorticoid receptors more strongly than other steroids like dexamethasone. It also has a lower influence on mineralocorticoid receptors, making it more targeted in its action. Once it enters the body, it works by activating certain pathways that reduce inflammation.

How Elocon works in the body

Mometasone is used to treat asthma by preventing the production of chemicals that cause inflammation. It does this by binding to special receptors found in cells. This binding causes the receptor to move to the nucleus of the cell, where it can block the transcription of pro-inflammatory molecules. Mometasone also blocks proteins like activator-protein-1 and NF-kappaB that help create inflammation. This all helps to reduce inflammation and relieve asthma symptoms.

When to interrupt dosage

The dose of Elocon is contingent upon the specified disorder, including Dermatitis, Eczematous caused by superficial Fungal skin contamination, Psoriasis and Skin Diseases, Eczematous. The measure of dosage is reliant upon the mode of delivery (e.g. Powder or Topical) provided in the table below.

Condition

Dosage

Administration

Dermatophytosis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Powder - Respiratory (inhalation), Powder, Aerosol - Respiratory (inhalation), Aerosol, Implant, Intrasinal, Implant - Intrasinal, Kit - Topical, Capsule, Capsule - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Kit, Spray, Spray - Nasal

Asthma

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Powder - Respiratory (inhalation), Powder, Aerosol - Respiratory (inhalation), Aerosol, Implant, Intrasinal, Implant - Intrasinal, Kit - Topical, Capsule, Capsule - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Kit, Spray, Spray - Nasal

Itching

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Powder - Respiratory (inhalation), Powder, Aerosol - Respiratory (inhalation), Aerosol, Implant, Intrasinal, Implant - Intrasinal, Kit - Topical, Capsule, Capsule - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Kit, Spray, Spray - Nasal

Atopic Dermatitis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Powder - Respiratory (inhalation), Powder, Aerosol - Respiratory (inhalation), Aerosol, Implant, Intrasinal, Implant - Intrasinal, Kit - Topical, Capsule, Capsule - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Kit, Spray, Spray - Nasal

prophylaxis of seasonal Allergic rhinitis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Powder - Respiratory (inhalation), Powder, Aerosol - Respiratory (inhalation), Aerosol, Implant, Intrasinal, Implant - Intrasinal, Kit - Topical, Capsule, Capsule - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Kit, Spray, Spray - Nasal

Hay Fever

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Powder - Respiratory (inhalation), Powder, Aerosol - Respiratory (inhalation), Aerosol, Implant, Intrasinal, Implant - Intrasinal, Kit - Topical, Capsule, Capsule - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Kit, Spray, Spray - Nasal

Seasonal Allergies

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Powder - Respiratory (inhalation), Powder, Aerosol - Respiratory (inhalation), Aerosol, Implant, Intrasinal, Implant - Intrasinal, Kit - Topical, Capsule, Capsule - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Kit, Spray, Spray - Nasal

Psoriasis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Powder - Respiratory (inhalation), Powder, Aerosol - Respiratory (inhalation), Aerosol, Implant, Intrasinal, Implant - Intrasinal, Kit - Topical, Capsule, Capsule - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Kit, Spray, Spray - Nasal

Psoriasis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Powder - Respiratory (inhalation), Powder, Aerosol - Respiratory (inhalation), Aerosol, Implant, Intrasinal, Implant - Intrasinal, Kit - Topical, Capsule, Capsule - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Kit, Spray, Spray - Nasal

Skin Diseases, Eczematous

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Powder - Respiratory (inhalation), Powder, Aerosol - Respiratory (inhalation), Aerosol, Implant, Intrasinal, Implant - Intrasinal, Kit - Topical, Capsule, Capsule - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Kit, Spray, Spray - Nasal

Communicable Diseases

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Powder - Respiratory (inhalation), Powder, Aerosol - Respiratory (inhalation), Aerosol, Implant, Intrasinal, Implant - Intrasinal, Kit - Topical, Capsule, Capsule - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Kit, Spray, Spray - Nasal

Systemic Treatment

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Powder - Respiratory (inhalation), Powder, Aerosol - Respiratory (inhalation), Aerosol, Implant, Intrasinal, Implant - Intrasinal, Kit - Topical, Capsule, Capsule - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Kit, Spray, Spray - Nasal

Nasal Decongestants

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Powder - Respiratory (inhalation), Powder, Aerosol - Respiratory (inhalation), Aerosol, Implant, Intrasinal, Implant - Intrasinal, Kit - Topical, Capsule, Capsule - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Kit, Spray, Spray - Nasal

Communicable Diseases

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Powder - Respiratory (inhalation), Powder, Aerosol - Respiratory (inhalation), Aerosol, Implant, Intrasinal, Implant - Intrasinal, Kit - Topical, Capsule, Capsule - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Kit, Spray, Spray - Nasal

Bacterial Infections

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Powder - Respiratory (inhalation), Powder, Aerosol - Respiratory (inhalation), Aerosol, Implant, Intrasinal, Implant - Intrasinal, Kit - Topical, Capsule, Capsule - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Kit, Spray, Spray - Nasal

Psoriasis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Powder - Respiratory (inhalation), Powder, Aerosol - Respiratory (inhalation), Aerosol, Implant, Intrasinal, Implant - Intrasinal, Kit - Topical, Capsule, Capsule - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Kit, Spray, Spray - Nasal

Dermatitis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Powder - Respiratory (inhalation), Powder, Aerosol - Respiratory (inhalation), Aerosol, Implant, Intrasinal, Implant - Intrasinal, Kit - Topical, Capsule, Capsule - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Kit, Spray, Spray - Nasal

Warnings

Elocon Contraindications

Condition

Risk Level

Notes

Asthma

Do Not Combine

Status Asthmaticus

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Mometasone Furoate may interact with Pulse Frequency

There are 20 known major drug interactions with Elocon.

Common Elocon Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The metabolism of Abemaciclib can be increased when combined with Mometasone furoate.

Acalabrutinib

Major

The metabolism of Acalabrutinib can be increased when combined with Mometasone furoate.

Aldesleukin

Major

The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Mometasone furoate.

Alectinib

Major

The metabolism of Alectinib can be increased when combined with Mometasone furoate.

Almotriptan

Major

The metabolism of Almotriptan can be decreased when combined with Mometasone furoate.

Elocon Toxicity & Overdose Risk

Taking too much of a mometasone furoate inhaler can cause symptoms like increased steroid levels and adrenal gland suppression. In animal studies, some toxic effects were seen at high doses, but humans may not be as sensitive. When given to pregnant patients, the benefits and risks should be carefully considered. It is not known if mometasone furoate passes into breast milk, so caution should be exercised when giving to nursing mothers. Children may experience a reduction in expected growth rate of about 1cm per year when on a mometasone furoate inhaler, and should be given the lowest effective dose available

image of a doctor in a lab doing drug, clinical research

Elocon Novel Uses: Which Conditions Have a Clinical Trial Featuring Elocon?

279 active studies are currently examining the potential benefits of Elocon in assuaging Atopic Dermatitis, Seasonal Allergies and Psoriasis.

Condition

Clinical Trials

Trial Phases

Asthma

97 Actively Recruiting

Phase 1, Phase 4, Not Applicable, Early Phase 1, Phase 2, Phase 3

Dermatophytosis

0 Actively Recruiting

Systemic Treatment

0 Actively Recruiting

Seasonal Allergies

0 Actively Recruiting

Itching

4 Actively Recruiting

Phase 3, Not Applicable, Early Phase 1

Hay Fever

0 Actively Recruiting

Skin Diseases, Eczematous

0 Actively Recruiting

Bacterial Infections

0 Actively Recruiting

Psoriasis

0 Actively Recruiting

prophylaxis of seasonal Allergic rhinitis

0 Actively Recruiting

Dermatitis

0 Actively Recruiting

Psoriasis

0 Actively Recruiting

Psoriasis

0 Actively Recruiting

Communicable Diseases

0 Actively Recruiting

Nasal Decongestants

7 Actively Recruiting

Phase 4, Not Applicable, Phase 3, Phase 2

Atopic Dermatitis

17 Actively Recruiting

Phase 2, Phase 3, Not Applicable, Phase 4, Phase 1

Communicable Diseases

0 Actively Recruiting

Elocon Reviews: What are patients saying about Elocon?

5

Patient Review

4/6/2009

Elocon for Psoriasis of Scalp

5

Patient Review

5/31/2009

Elocon for Skin Condition

5

Patient Review

8/1/2009

Elocon for Skin Condition

I work with wood a lot, and it really dries out my hands. This product helps to alleviate that problem almost overnight!

5

Patient Review

3/1/2011

Elocon for Rash

This topical treatment has worked wonders! The redness, itching and scaling are almost completely gone.

5

Patient Review

4/7/2015

Elocon for Atopic Dermatitis

Elocon did help with the redness and swelling of my thumb and nail infection, but I still have some skin peeling and irritation around the base of the nail. I'm currently waiting on lab results to see if there is a fungal infection present as well.

5

Patient Review

10/23/2011

Elocon for Rash

I never had the chance to use Elocon because my insurance wouldn't cover it, so I don't know if it's effective or not.

5

Patient Review

8/3/2010

Elocon for Psoriasis of Scalp

My friend recommended this to me for a rash I kept getting on my upper, inner arms and it worked like a charm! If the rash comes back, I'll be sure to ask my doctor for a prescription.

5

Patient Review

10/8/2020

Elocon for Rash

This cream has been the most effective at treating my eczema. I've tried many other creams and treatments over the years, but this one always helps to quickly clear up any flare-ups overnight.

3.7

Patient Review

10/25/2009

Elocon for Skin Condition

I was given this medication for my psoriasis, but it seems to have made things worse.

2.7

Patient Review

9/8/2009

Elocon for Plaque Psoriasis

Elocon was prescribed by my ENT to address the itchiness I was experiencing in my ear as a result of allergies/sinus problems. It works great, though you have to be careful not to use too much.

1

Patient Review

1/4/2021

Elocon for Skin Rash that Becomes Thick & Discolored From Rubbing It

The new formula for this cream is complete garbage and doesn't work at all. It's a shame because it used to be really effective.

1

Patient Review

11/27/2010

Elocon for Plaque Psoriasis

Elocon 0.1 has been a game-changer for me in terms of preventing earwax buildup. I saw my doctor less frequently and experienced fewer problems overall.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about elocon

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Elocon cream prescription only?

"Elocon is a medication that is only available with a prescription that is used to treat eczema that is moderate to severe. Elocon contains mometasone furoate 0.1% as its active ingredient and is available as a cream or ointment. It should be thinly applied only once a day to the areas of the body that are affected."

Answered by AI

Does Elocon lighten skin?

"Q: Does Elocon cream have skin lightening properties?

A: No, Elocon cream is not a skin lightening cream. This cream is used to treat skin conditions associated with itching, swelling, redness and discomfort, such as psoriasis, dermatitis, eczema, etc."

Answered by AI

Can Elocom be used on face?

"The maximum amount of Mometasone that should be used is 5 days on the face, scalp, skin-fold areas, and groin. For the body, the maximum amount of time it should be used is 3 weeks. Factors such as body weight, other medical conditions, and other medications can affect how much of the medication is needed."

Answered by AI

What is the cream Elocon used for?

"Dermatitis is a general term for inflammation of the skin.

Elocon Cream can be used to reduce redness and itchiness caused by psoriasis or dermatitis in both adults and children."

Answered by AI

Clinical Trials for Elocon

Image of University of California, Berkeley in Berkeley, United States.

Air Cleaners for Asthma and COPD

Any Age
All Sexes
Berkeley, CA

Fine particulate matter (PM2.5) is a type of air pollution made up of extremely tiny particles that can harm our health. Because PM2.5 particles are so small, they can travel deep into the lungs when inhaled. Exposure to PM2.5 can worsen asthma, cause breathing problems, increase the risk of heart attacks, and lead to early death, especially for people with existing heart or lung conditions. In California's Bayview Hunters Point (BVHP), a San Francisco community already facing high levels of air pollution and health impacts, sources of PM2.5 include industrial activity, commuter traffic, heavy-duty diesel trucks, freight trains, and port and maritime activities. The Reducing Exposure with Air Cleaners and Technology (REACT) Study is a partnership between University of California (UC) Berkeley, UC San Francisco, and Brightline Defense. The goal is to see if air cleaners (also called air purifiers) can help reduce indoor PM2.5 levels and improve respiratory health. For this study, the investigators will be recruiting 100 households in BVHP to participate. In each home, indoor PM2.5 levels and the health status of household members who are 13 years old or older and have asthma or chronic obstructive pulmonary disease (COPD) will be monitored. Each home will be part of the study for 90 to 120 days, depending on scheduling. Households must reside in BVHP for the duration of the study and not have used an air cleaner in their home within the last 6 months. On Day 1, each household will receive a PurpleAir indoor air quality monitor to measure PM2.5 levels in their home. * For the first 30 days, the investigators will measure the home's normal air quality (baseline). * After 30 days, each household will receive an air cleaner with information about how to best use it. * At that point, a PM2.5 indicator light will be turned on for half of the PurpleAir monitors. For the other half, indicator light will be kept turned off. This helps the investigators study whether seeing the air quality in real time changes how people use the air cleaner. * For the next 30 days, indoor PM2.5 levels will continue to be monitored. How often the air cleaner is used will also be tracked with smart plug data loggers. * After 60 days, more training and support will be offered to all participants and monitoring will continue over the final 30 days of the study.

Waitlist Available
Has No Placebo

University of California, Berkeley (+2 Sites)

Chelsea V Preble, PhD

Image of Allergy and Clinical Immunology Associates in Pittsburgh, United States.

Tilrekimig for Asthma

12 - 80
All Sexes
Pittsburgh, PA

The purpose of this clinical study is to learn about the safety and effects of the study medicine (called tilrekimig) for the potential treatment of severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life of people who are affected. The study is seeking participants who: * Have a history of severe asthma for at least 12 months * Have had at least 2 asthma attacks (also known as exacerbations) within the last 12 months All participants will be given shots of study medicine or a placebo at the study clinic. Tilrekimig or the placebo will be given about every 4 weeks during the study. The study will compare the experiences of people receiving tilrekimig to those people who receive the placebo. This will help determine if tilrekimig is safe and effective.

Phase 3
Recruiting

Allergy and Clinical Immunology Associates (+10 Sites)

Pfizer CT.gov Call Center

Pfizer

Image of Ontario Tech University in Oshawa, Canada.

Temperature & Humidity Exposure for Asthma

11 - 18
All Sexes
Oshawa, Canada

The goal of this clinical study is to learn how different temperature and humidity conditions affect breathing, lung function, exercise capacity, symptoms, and other physical responses in children and youth aged 11 to 18 years with asthma, compared with age- and sex-matched children and youth without asthma. The main questions it aims to answer are: * How do different temperature and humidity conditions affect lung function, breathing symptoms, exercise capacity, and physiological responses in children and youth with asthma? * Do children and youth with asthma respond differently to these environmental conditions than children and youth without asthma? * Do sex and gender influence these responses? Researchers will compare children and youth with asthma to age- and sex-matched children and youth without asthma to see if temperature and humidity exposures have different effects on breathing, exercise performance, symptoms, and physiological responses. Participants will: * Attend two study visits in a climate-controlled chamber. * Be exposed to hot, cold, and varying humidity conditions for short periods of time. * Complete breathing tests and exercise testing before, during, and after each exposure. * Have symptoms, physical activity, and physiological responses monitored throughout the study.

Waitlist Available
Has No Placebo

Ontario Tech University

Have you considered Elocon clinical trials?

We made a collection of clinical trials featuring Elocon, we think they might fit your search criteria.
Go to Trials
Image of Children's Hospital Los Angeles in Los Angeles, United States.

Wearable Stethoscope for Childhood Asthma

4 - 17
All Sexes
Los Angeles, CA

The goal of this clinical trial is to evaluate a prototype wearable stethoscope designed to record lung sounds and assess asthma control in children and adolescents with asthma aged 4 to 17 years who are able to perform spirometry. The study aims to determine whether the prototype wearable stethoscope can accurately detect clinically meaningful changes in lung sounds associated with asthma control and response to bronchodilator treatment. The main questions it aims to answer are: * Does the prototype wearable stethoscope demonstrate agreement with recordings obtained from commercially available Thinklabs One Digital Stethoscopes in identifying normal and abnormal lung sounds? * Are lung sounds detected by the prototype wearable stethoscope associated with asthma symptom control as measured by the Childhood Asthma Control Test (cACT) or Asthma Control Test (ACT) Researchers will compare recordings obtained from the prototype wearable stethoscope with recordings obtained from FDA-cleared Thinklabs One Digital Stethoscopes to evaluate the prototype device's ability to detect abnormal lung sounds and changes in lung sounds following bronchodilator treatment.

Waitlist Available
Has No Placebo

Children's Hospital Los Angeles

Roberta Kato, MD

Image of SMS Clinical Research LLC in Garland, United States.

Tilrekimig for Severe Asthma

12 - 80
All Sexes
Garland, TX

The purpose of this clinical study is to learn about the safety and effects of the study medicine (called tilrekimig) for the potential treatment of severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life of people who are affected. The study is seeking participants who: * Have a history of severe asthma for at least 12 months * Have had at least 2 asthma attacks (also known as exacerbations) within the last 12 months All participants will be given shots of study medicine or a placebo at the study clinic. The study will compare the experiences of people receiving tilrekimig to those people who receive the placebo. This will help determine if tilrekimig is safe and effective.

Phase 3
Recruiting

SMS Clinical Research LLC (+12 Sites)

Pfizer CT.gov Call Center

Pfizer

Have you considered Elocon clinical trials?

We made a collection of clinical trials featuring Elocon, we think they might fit your search criteria.
Go to Trials
Image of University of Wisconsin in Madison, United States.

Mouthwash for Asthma

18+
All Sexes
Madison, WI

This study aims to determine whether an extra virgin olive oil-based water (EVOOW) mixture removes more fluticasone propionate (FP) from the mouth than water alone. More effective removal of residual FP deposits may help reduce the risk of complications associated with inhaled corticosteroid use, including obstructive sleep apnea (OSA), oral candidiasis (thrush), and speech and swallowing dysfunction. Participants will attend two separate testing visits, during which they will rinse and gargle with either EVOOW or water, after receiving 1 puff if fluticasone propionate. The visits will be scheduled 7-10 days apart. Total participation will last up to 3 weeks.

Phase 4
Waitlist Available

University of Wisconsin

Mihaela Teodorescu, MD, MS

Have you considered Elocon clinical trials?

We made a collection of clinical trials featuring Elocon, we think they might fit your search criteria.
Go to Trials